"The study of brain networks in brain tumor surgery holds promise for improving surgical outcomes. By understanding these networks, surgeons can minimize damage to areas responsible for critical functions like language, thought and emotion. Connectomics with Intraoperative stimulation will be the standard of care in coming days. Additionally, studying how surgery impacts networks can guide rehabilitation efforts to help patients recover lost cognitive abilities.
I can see Brain Sight AI expanding wings to stroke rehabilitation, chronic pain management coupled with TMS, psychiatric disorders. "
Dr. Abhirama Chandra Gabbita
Clinical Study Partners
Being Used By
BrainSightAI Bags $5 Mn Led By IAN Alpha Fund and others
BrainSightAI secured $5 Mn in a Pre-Series A funding round led by IAN Alpha Fund, with participation from IvyCap Ventures, Silver Needle, and its existing investors
With the newly raised capital, it plans to expand BrainSightAI’s presence in India, increasing its reach in Tier I cities while also extending to Tier II cities
The Bengaluru-based company also plans to pursue FDA certification, opening access to the US and allied markets. Read more
Awarded the Top Innovator at the ET Startup awards 2024
Innovation in the mental health and neurology space has a massive potential to transform lives, the ET Startup Awards 2024 jury said, as it zeroed in on BrainSight AI as the winner in the Top Innovator category. While space technology startup SatSure was in contention, the potential use of artificial intelligence in reading complex MRI scans and its eventual impact on humans tilted the jury towards BrainSight AI. Read more
